At a vaccination centre in the Philippines.


Philippines approves Sinovac Covid-19 vaccine


MANILA – The Philippines has approved Sinovac Biotech’s Covid-19 vaccine for emergency use, said Food and Drug Administration (FDA) chief Eric Domingo on Monday (February 22).

Domingo said the Sinovac vaccine is safe with an efficacy rate of 65.3 to 91.2 percent.

It is the third vaccine to be granted an emergency use authorization (EUA) in the country after AstraZeneca and Pfizer-BioNTech’s Covid-19 vaccines that got the EUA from FDA last month.

In a briefing, Domingo said Sinovac’s safety profile is good, with only mild to moderate side effects, such as pain in the arm.

However, he said the vaccine is recommended for use on clinically healthy members of the community aged between 18 to 59 years old.

Meanwhile, the Department of Health said specific details as to the shipment dates and volume of the 600,000 doses of Sinovac are currently being finalized by Secretary Carlito Galvez Jr.

“Timeline of COVAX doses and other procured vaccines are also currently being finalized by the vaccine cluster,” according to DOH in a statement. CAM/Expat Media

For all the latest news from the UAE and the world, follow us on Facebook, Twitter and Instagram and subscribe to our YouTube page


ADVERTISE HERE Find or post new jobs, motor ads and classifieds

Explore Expat Media